TrialStroke2019

Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.

Matthew E Ehrlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.